| 1 |
Wallace DC. Mitochondrial DNA mutations in disease and aging[J]. Environ Mol Mutagen, 2010, 51(5): 440-450.
|
| 2 |
Krieg RC, Knuechel R, Schiffmann E, et al. MItochondrial proteome：cancer-altered metabolism associated with cytochrome c oxidase subunit level variation[J]. Proteomics, 2004, 4(9): 2789-2795.
|
| 3 |
Ksizeakowska-Łakoma K, Zyła M, Wilczyński JR. Mitochondrial dysfunction in cancer[J]. Prz Menopauzalny, 2014, 13(2): 136144.
|
| 4 |
Wallace DC. Mitochondrial DNA Sequence Variation in Human Evolution and Disease[J]. Proc Natl Acad Sci U S A, 1994, 91(19): 8739-8746.
|
| 5 |
Kang D, Hamasaki N. Mitochondrial oxidative stress and mitochondrial DNA[J]. Clin Chem Lab Med, 2003, 41(10): 1281-1288.
|
| 6 |
Suzuki M, Toyooka S, Miyajima K, et al. Alterations in the mitochondrial displacement loop in lung cancers[J]. Clin Cancer Res, 2003, 9(15): 5636-5641.
|
| 7 |
Anderson S, Bankier AT, Barrell BG, et al. Sequence and organization of the human mitochondrial genome[J]. Nature (Lond), 290(5806): 457-465.
|
| 8 |
Penta JS, Johnson FM, Wachsman JT, et al. Mitochondrial DNA in human malignancy[J]. Mutat Res, 2001, 488(2): 119-133.
|
| 9 |
Fliss MS, Usadel H, Caballero OL, et al. Facile Detection of Mitochondrial DNA Mutations in Tumors and Bodily Fluids[J]. Science, 2000, 287(5460): 2017-2019.
|
| 10 |
Yeh JJ, Lunetta KL, van Orsouw NJ, et al. Somatic mitochondrial DNA (mtDNA) mutations in papillary thyroid carcinomas and differential mtDNA sequence variants in cases with thyroid tumours[J]. Oncogene, 2000, 19(16): 2060-2066.
|
| 11 |
Morais R, Desjardins P, Turmel C, et al. Development and characterization of continuous avian cell lines depleted of mitochondrial DNA[J]. In Vitro Cell Dev Biol, 1988, 24(7): 649-658.
|
| 12 |
Liu F, Sanin DE, Wang X. Mitochondrial DNA in Lung Cancer[J]. Adv Exp Med Biol, 2017, 1038: 9-22.
|
| 13 |
Dai JG, Zhang ZY, Liu QX, et al. Mitochondrial Genome Microsatellite Instability and Copy Number Alteration in Lung Carcinomas[J]. Asian Pac J Cancer Prev, 2013, 14(4): 2393-2399.
|
| 14 |
Lee HC, Yin PH, Lin JC, et al. Mitochondrial genome instability and mtDNA depletion in human cancers[J]. Ann NY Acad Sci, 2005, 1042(1): 109-122.
|
| 15 |
Reznik E, Miller ML, Şenbabaoğlu Y, et al. Mitochondrial DNA copy number variation across human cancers[J]. Elife, 2016, 5: e10769.
|
| 16 |
Bonner MR, Shen M, Liu CS, et al. Mitochondrial DNA content and lung cancer risk in Xuan Wei, China[J]. Lung Cancer, 2009, 63(3): 331-334.
|
| 17 |
Hosgood HD 3rd, Liu CS, Rothman N, et al. Mitochondrial DNA copy number and lung cancer risk in a prospective cohort study[J]. Carcinogenesis, 2010, 31(5): 847-849.
|
| 18 |
Hayes RB, Sigurdson A, Moore L, et al. Methods for etiologic and early marker investigations in the PLCO trial[J]. Mutat Res, 2005, 592(1-2): 147-154.
|
| 19 |
Zheng W, Chow WH, Yang G, et al. The Shanghai Women′s Health Study: Rationale, Study Design, and Baseline Characteristics[J]. Am J Epidemiol, 2005, 162(11): 1123-1131.
|
| 20 |
Kim C, Bassig BA, Seow WJ, et al. Pooled analysis of mitochondrial DNA copy number and lung cancer risk in three prospective studies[J]. Cancer Epidemiol Biomarkers Prev, 2014, 23(12): 2977-2980.
|
| 21 |
Meng S, Vivo ID, Liang L, et al. Pre-diagnostic leukocyte mitochondrial DNA copy number and risk of lung cancer[J]. Oncotarget, 2016, 7(19): 27307-27312.
|
| 22 |
Hou YL, Chen JJ, Wu YF, et al. Clinical significance of serum mitochondrial DNA in lung cancer[J]. Clin Biochem, 2013, 46(15): 1474-1477.
|
| 23 |
Lin CS, Wang LS, Tsai CM, et al. Low copy number and low oxidative damage of mitochondrial DNA are associated with tumor progression in lung cancer tissues after neoadjuvant chemotherapy[J]. Interact Cardiovasc Thorac Surg, 2008, 7(6): 954-958.
|
| 24 |
Huang CY, Chen YM, Wu CH, et al. Circulating free mitochondrial DNA concentration and its association with erlotinib treatment in patients with adenocarcinoma of the lung[J]. Oncol Lett, 2014, 7(6): 2180-2184.
|
| 25 |
Xu H, He W, Jiang HG, et al. Prognostic value of mitochondrial DNA content and G10398A polymorphism in non-small cell lung cancer[J]. Oncology reports, 2013, 30(6): 3006-3012.
|
| 26 |
Brandon M, Baldi P, Wallace DC. Mitochondrial mutations in cancer [J]. Oncogene, 2006, 25(34): 4647-4662.
|
| 27 |
Shidara Y, Yamagata K, Kanamori T, et al. Positive Contribution of Pathogenic Mutations in the Mitochondrial Genome to the Promotion of Cancer by Prevention from Apoptosis[J]. Cancer Research, 2005, 65(5): 1655-1663.
|
| 28 |
Kulawiec M, Owens KM, Singh KK. Cancer cell mitochondria confer apoptosis resistance and promote metastasis[J]. Cancer Biol Ther, 2009, 8(14): 1378-1385.
|
| 29 |
Sanchezcespedes M, Parrella P, Nomoto S, et al. Identification of a Mononucleotide Repeat as a Major Target for Mitochondrial DNA Alterations in Human Tumors[J]. Cancer Res, 2001, 61(19): 70157019.
|
| 30 |
Matsuyama W, Nakagawa M, Wakimoto J, et al. Mitochondrial DNA mutation correlates with stage progression and prognosis in non-small cell lung cancer[J]. Hum Mutat, 2003, 21(4): 441-443.
|
| 31 |
Jin X, Zhang J, Gao Y, et al. Relationship between mitochondrial DNA mutations and clinical characteristics in human lung cancer[J]. Mitochondrion, 2007, 7(5): 347-353.
|
| 32 |
Dasgupta S, Soudry E, Mukhopadhyay N, et al. Mitochondrial DNA mutations in respiratory complex-I in never-smoker lung cancer patients contribute to lung cancer progression and associated with EGFR gene mutation[J]. J Cell Physiol, 2012, 227(6): 2451-2460.
|
| 33 |
Kazdal D, Harms A, Endris V, et al. Prevalence of somatic mitochondrial mutations and spatial distribution of mitochondria in non-small cell lung cancer[J]. Br J Cancer, 2017, 117(2): 220-226.
|
| 34 |
Zheng S, Qian P, Li F, et al. Association of mitochondrial DNA variations with lung cancer risk in a Han Chinese population from southwestern China[J]. PloS one, 2012, 7(2): e31322.
|
| 35 |
Wang Z, Choi S, Lee J, et al. Mitochondrial Variations in Non-Small Cell Lung Cancer (NSCLC) Survival[J]. Cancer Inform, 2015, 14(Suppl 1): 1-9.
|
| 36 |
Matsuyama W, Nakagawa M, Wakimoto J, et al. Mitochondrial DNA mutation correlates with stage progression and prognosis in non-small cell lung cancer[J]. Hum Mutat, 2003, 21(4): 441-443.
|
| 37 |
Ding C, Li R, Wang P, et al. Identification of sequence polymorphisms in the D-loop region of mitochondrial DNA as a risk factor for lung cancer[J]. Mitochondrial DNA, 2012, 23(4): 251-254.
|
| 38 |
Ding C, Li R, Wang P, et al. Sequence polymorphisms of the mitochondrial displacement loop and outcome of non-small cell lung cancer[J]. Exp Ther Med, 2012, 3(5): 861-864.
|
| 39 |
Koshikawa N, Akimoto M, Hayashi JI, et al. Association of predicted pathogenic mutations in mitochondrial ND genes with distant metastasis in NSCLC and colon cancer[J]. Sci Rep, 2017, 7(1): 15535.
|
| 40 |
Qi Y, Wei Y, Wang Q, et al. Heteroplasmy of mutant mitochondrial DNA A10398G and analysis of its prognostic value in non-small cell lung cancer[J]. Oncol Lett, 2016, 12(5): 3081-3088.
|
| 41 |
Kalainayakan SP, Fitzgerald KE, Konduri PC, et al. Essential roles of mitochondrial and heme function in lung cancer bioenergetics and tumorigenesis[J]. Cell Biosci, 2018, 8: 56.
|
| 42 |
Ellinghaus P, Heisler I, Unterschemmann K, et al. BAY 87-2243, a highly potent and selective inhibitor of hypoxia-induced gene activation has antitumor activities by inhibition of mitochondrial complex I[J]. Cancer Med, 2013, 2(5): 611-624.
|
| 43 |
Szczesny B, Marcatti M, Zatarain JR, et al. Inhibition of hydrogen sulfide biosynthesis sensitizes lung adenocarcinoma to chemotherapeutic drugs by inhibiting mitochondrial DNA repair and suppressing cellular bioenergetics[J]. Sci Rep, 2016, 6: 361251.
|
| 44 |
Trivedi M, Singh A, Talekar M, et al. MicroRNA-34a encapsulated in hyaluronic acid nanoparticles induces epigenetic changes with altered mitochondrial bioenergetics and apoptosis in non-small-cell lung cancer cells[J]. Sci Rep, 2017, 7(1): 3636.
|